Invention Grant
- Patent Title: Hybridoma cell line G250 and its use for producing monoclonal antibodies
-
Application No.: US12342512Application Date: 2008-12-23
-
Publication No.: US09605075B2Publication Date: 2017-03-28
- Inventor: Egbert Oosterwijk , Sven Warnaar , Stefan Ullrich
- Applicant: Egbert Oosterwijk , Sven Warnaar , Stefan Ullrich
- Applicant Address: DE Munich
- Assignee: WILEX AG
- Current Assignee: WILEX AG
- Current Assignee Address: DE Munich
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/30 ; A61K47/48 ; A61K39/00
Abstract:
This invention relates to a hybridoma cell line which is capable of producing the monoclonal antibody G250. Furthermore, the invention describes the method of employing such cell line for the production and manufacture of monoclonal antibody G250 as well as derivatives thereof such as chimeric and humanized G250 antibodies.
Public/Granted literature
- US20090274620A1 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies Public/Granted day:2009-11-05
Information query
